Targeted Protein Degradation Market Size, Share, Trends, & Industry Analysis Report By Technology, By Application, By Therapeutic Area, By End User, and By Region

Description

List of Tables

New industry analysis projects a USD 3,531.80 Million targeted protein degradation market by 2034 as the first FDA-approved PROTAC therapy, expanding molecular glue programs, and advancing late-stage clinical pipelines reshape the next phase of precision therapeutics.

Market Size 2025

Forecast 2034

CAGR 2026-2034

Leading Region

USD 687.90 Million

USD 3,531.80 Million

19.9%

North America (50.0%)

Polaris Market Research & Consulting has released its Targeted Protein Degradation Market Report 2026-2034. The market was valued at USD 687.90 million in 2025 and is projected to reach USD 3,531.80 million by 2034, registering a CAGR of 19.9% during the forecast period. Market growth is supported by the approval of the first PROTAC therapy, increasing pharmaceutical investment in targeted protein degradation platforms, expanding molecular glue development programs, and continued progress across oncology and immunology clinical pipelines.

The recent industrial changes have added more value to the business prospects of protein degradation. In May 2026, Arvinas received approval from the FDA for their drug VEPPANU (vepdegestrant) and marked the first ever approved use of PROTACs. Later that month, Arvinas and Pfizer entered an agreement granting Rigel exclusive global development, manufacturing, and commercialization rights for VEPPANU.

"The approval of the first PROTAC therapy marks an important transition for targeted protein degradation from scientific validation to commercial execution. Organizations that combine differentiated degrader platforms with strong clinical evidence, manufacturing capabilities, commercialization expertise, and strategic partnerships are expected to strengthen their competitive position as the market continues to mature." - Prajakta Bengale, Senior Healthcare Analyst

Targeted Protein Degradation Market Investment Signals 2026

Investment Theme

Market Signal

Business Implication

Commercialization Readiness

FDA approval of the first PROTAC therapy followed by the transfer of global commercialization rights for VEPPANU

Highlights the importance of launch capabilities, manufacturing expertise, and market access alongside platform innovation

Late-Stage Clinical Development

C4 Therapeutics initiated the registrational Phase 2 MOMENTUM study for cemsidomide

Supports investment in programs with defined regulatory pathways and late-stage clinical milestones

Combination Therapy Expansion

C4 Therapeutics advanced a Phase 1b combination study of cemsidomide with elranatamab

Reinforces opportunities for combination treatment strategies across targeted protein degradation programs

Regulatory Validation

FDA approval established the first commercial precedent for a PROTAC therapy

Strengthens confidence in companies with clinically validated degrader platforms and regulatory progress

Source: Polaris Market Research Analysis

Three Market Developments Reshaping the Targeted Protein Degradation Industry in 2026

Regulatory Approval Is Accelerating Commercial Adoption

The approval of the first PROTAC therapy has established an important commercial and regulatory benchmark for targeted protein degradation. This milestone provides greater confidence in the therapeutic approach while supporting continued investment across clinical development, manufacturing, and commercialization activities.

Clinical Pipelines Remain Active Past Early-Stage Discoveries

Protein degradation technology companies continue their progress toward clinical development in many late-stage pipelines for various disease indications within oncology and beyond. Registrational studies and combination therapy efforts increase the potential to commercialize products and provide future market opportunities.

Strategic Partnerships Enhance Value of Platforms

Pharmaceutical firms are continuously developing their target protein degradation portfolios through strategic licensing deals and clinical development alliances. The alliances are enabling faster product development and enhanced access to manufacturing expertise, regulatory capabilities, and commercialization infrastructure.

About the Polaris Targeted Protein Degradation Market Report 2026-2034

The report provides comprehensive analysis of market size, segmentation, regional trends, competitive landscape, and technology developments across the targeted protein degradation ecosystem. It is designed for pharmaceutical companies, biotechnology firms, contract research organizations, investors, academic research institutions, and healthcare stakeholders seeking strategic insights into emerging market opportunities, clinical innovation, partnership activity, and competitive positioning.

Report coverage: Market size and CAGR by technology, application, therapeutic area, and end user | Regional analysis across 5 regions with country-level breakdowns | Competitive landscape and company benchmarking | Technology and innovation assessment | Regulatory environment analysis | PDF and Excel formats | Customization available by country, region, and segment

Key Companies Profiled

Amphista Therapeutics Ltd.

Arvinas Inc.

Betta Pharmaceuticals Co. Ltd.

Bristol Myers Squibb Company

C4 Therapeutics Inc.

Cullgen Inc.

Dialectic Therapeutics Inc.

Kymera Therapeutics Inc.

Monte Rosa Therapeutics Inc.

Nurix Therapeutics Inc.

Pfizer Inc.

Relay Therapeutics Inc.

Market Segments Covered in the Targeted Protein Degradation Market Report

By Technology Outlook (Revenue, USD Billion, 2021-2034)

PROTACs (Heterobifunctional Degraders)

Molecular Glues

LYTACs (Lysosome-Targeting Chimeras)

Degrader-Antibody Conjugates

Other Induced-Proximity Modalities

By Application Outlook (Revenue, USD Billion, 2021-2034)

Therapy Development

Target Identification and Validation

Drug Discovery Research Tools

Others

By Therapeutic Area Outlook (Revenue, USD Billion, 2021-2034)

Oncology

Immunology and Inflammation

Neurology and Neurodegenerative Diseases

Infectious Diseases

Others

By End User Outlook (Revenue, USD Billion, 2021-2034)

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs) and Specialist Providers

Academic and Research Institutions

Others

By Regional Outlook (Revenue, USD Billion, 2021-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5247

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Targeted Protein Degradation Market Insights

4.1. Targeted Protein Degradation Market - Market Snapshot
4.2. Targeted Protein Degradation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. FDA approval of VEPPANU (vepdegestrant) established the first commercial PROTAC therapy.
  - 4.2.1.2. Rising molecular glue licensing activity and strategic pharmaceutical partnerships are accelerating market growth.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Oral exposure, ternary-complex productivity, and proteome-wide selectivity
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Targeted Protein Degradation Market Trends
4.6. Value Chain Analysis

5. Global Targeted Protein Degradation Market, by Technology

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
5.3. PROTACs (Heterobifunctional Degraders)
- 5.3.1. Global Targeted Protein Degradation Market, by PROTACs (Heterobifunctional Degraders), by Region, 2021-2034 (USD Million)
5.4. Molecular Glues
- 5.4.1. Global Targeted Protein Degradation Market, by Molecular Glues, 2021-2034 (USD Million)
5.5. LYTACs (Lysosome-Targeting Chimeras)
- 5.5.1. Global Targeted Protein Degradation Market, by LYTACs (Lysosome-Targeting Chimeras), by Region, 2021-2034 (USD Million)
5.6. Degrader-Antibody Conjugates
- 5.6.1. Global Targeted Protein Degradation Market, by Degrader-Antibody Conjugates, by Region, 2021-2034 (USD Million)
5.7. Other Induced-Proximity Modalities
- 5.7.1. Global Targeted Protein Degradation Market, by Other Induced-Proximity Modalities, by Region, 2021-2034 (USD Million)

6. Global Targeted Protein Degradation Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
6.3. Therapy Development
- 6.3.1. Global Targeted Protein Degradation Market, by Therapy Development, by Region, 2021-2034 (USD Million)
6.4. Target Identification and Validation
- 6.4.1. Global Targeted Protein Degradation Market, by Target Identification and Validation, by Region, 2021-2034 (USD Million)
6.5. Drug Discovery Research Tools
- 6.5.1. Global Targeted Protein Degradation Market, by Drug Discovery Research Tools, by Region, 2021-2034 (USD Million)
6.6. Others
- 6.6.1. Global Targeted Protein Degradation Market, by Others, by Region, 2021-2034 (USD Million)

7. Global Targeted Protein Degradation Market, by Therapeutic

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
7.3. Oncology
- 7.3.1. Global Targeted Protein Degradation Market, by Oncology, by Region, 2021-2034 (USD Million)
7.4. Immunology and Inflammation
- 7.4.1. Global Targeted Protein Degradation Market, by Immunology and Inflammation, by Region, 2021-2034 (USD Million)
7.5. Neurology and Neurodegenerative Diseases
- 7.5.1. Global Targeted Protein Degradation Market, by Neurology and Neurodegenerative Diseases, by Region, 2021-2034 (USD Million)
7.6. Infectious Diseases
- 7.6.1. Global Targeted Protein Degradation Market, by Infectious Diseases, by Region, 2021-2034 (USD Million)
7.7. Others
- 7.7.1. Global Targeted Protein Degradation Market, by Others, by Region, 2021-2034 (USD Million)

8. Global Targeted Protein Degradation Market, by End-user

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
8.3. Pharmaceutical and Biotechnology Companies
- 8.3.1. Global Targeted Protein Degradation Market, by Pharmaceutical and Biotechnology Companies, by Region, 2021-2034 (USD Million)
8.4. Contract Research Organizations (CROs) and Specialist Providers
- 8.4.1. Global Targeted Protein Degradation Market, by Contract Research Organizations (CROs) and Specialist Providers, by Region, 2021-2034 (USD Million)
8.5. Academic and Research Institutions
- 8.5.1. Global Targeted Protein Degradation Market, by Academic and Research Institutions, by Region, 2021-2034 (USD Million)
8.6. Others
- 8.6.1. Global Targeted Protein Degradation Market, by Others, by Region, 2021-2034 (USD Million)

9. Global Targeted Protein Degradation Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Targeted Protein Degradation Market Assessment, By Geography, 2021-2034 (USD Million)
9.3. Targeted Protein Degradation Market - North America
- 9.3.1. North America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
- 9.3.2. North America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
- 9.3.3. North America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
- 9.3.4. North America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.3.5. Targeted Protein Degradation Market - U.S.
  - 9.3.5.1. U.S.: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.3.5.2. U.S.: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.3.5.3. U.S.: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.3.5.4. U.S.: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.3.6. Targeted Protein Degradation Market - Canada
  - 9.3.6.1. Canada: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.3.6.2. Canada: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.3.6.3. Canada: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.3.6.4. Canada: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
9.4. Targeted Protein Degradation Market - Europe
- 9.4.1. Europe: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
- 9.4.2. Europe: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
- 9.4.3. Europe: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
- 9.4.4. Europe: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.5. Targeted Protein Degradation Market - UK
  - 9.4.5.1. UK: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.5.2. UK: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.5.3. UK: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.5.4. UK: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.6. Targeted Protein Degradation Market - France
  - 9.4.6.1. France: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.6.2. France: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.6.3. France: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.6.4. France: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.7. Targeted Protein Degradation Market - Germany
  - 9.4.7.1. Germany: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.7.2. Germany: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.7.3. Germany: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.7.4. Germany: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.8. Targeted Protein Degradation Market - Italy
  - 9.4.8.1. Italy: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.8.2. Italy: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.8.3. Italy: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.8.4. Italy: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.9. Targeted Protein Degradation Market - Spain
  - 9.4.9.1. Spain: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.9.2. Spain: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.9.3. Spain: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.9.4. Spain: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.10. Targeted Protein Degradation Market - Netherlands
  - 9.4.10.1. Netherlands: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.10.2. Netherlands: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.10.3. Netherlands: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.10.4. Netherlands: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.11. Targeted Protein Degradation Market - Russia
  - 9.4.11.1. Russia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.11.2. Russia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.11.3. Russia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.11.4. Russia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.4.12. Targeted Protein Degradation Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
9.5. Targeted Protein Degradation Market - Asia Pacific
- 9.5.1. Asia Pacific: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
- 9.5.2. Asia Pacific: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
- 9.5.3. Asia Pacific: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
- 9.5.4. Asia Pacific: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.5. Targeted Protein Degradation Market - China
  - 9.5.5.1. China: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.5.2. China: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.5.3. China: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.5.4. China: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.6. Targeted Protein Degradation Market - India
  - 9.5.6.1. India: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.6.2. India: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.6.3. India: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.6.4. India: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.7. Targeted Protein Degradation Market - Malaysia
  - 9.5.7.1. Malaysia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.7.2. Malaysia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.7.3. Malaysia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.7.4. Malaysia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.8. Targeted Protein Degradation Market - Japan
  - 9.5.8.1. Japan: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.8.2. Japan: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.8.3. Japan: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.8.4. Japan: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.9. Targeted Protein Degradation Market - Indonesia
  - 9.5.9.1. Indonesia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.9.2. Indonesia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.9.3. Indonesia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.9.4. Indonesia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.10. Targeted Protein Degradation Market - South Korea
  - 9.5.10.1. South Korea: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.10.2. South Korea: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.10.3. South Korea: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.10.4. South Korea: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.11. Targeted Protein Degradation Market - Australia
  - 9.5.11.1. Australia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.11.2. Australia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.11.3. Australia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.11.4. Australia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.5.12. Targeted Protein Degradation Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
9.6. Targeted Protein Degradation Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
- 9.6.2. Middle East & Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
- 9.6.3. Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
- 9.6.4. Middle East & Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.6.5. Targeted Protein Degradation Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.6.6. Targeted Protein Degradation Market - UAE
  - 9.6.6.1. UAE: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.6.6.2. UAE: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.6.6.3. UAE: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.6.6.4. UAE: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.6.7. Targeted Protein Degradation Market - Israel
  - 9.6.7.1. Israel: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.6.7.2. Israel: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.6.7.3. Israel: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.6.7.4. Israel: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.6.8. Targeted Protein Degradation Market - South Africa
  - 9.6.8.1. South Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.6.8.2. South Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.6.8.3. South Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.6.8.4. South Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.6.9. Targeted Protein Degradation Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
9.7. Targeted Protein Degradation Market - Latin America
- 9.7.1. Latin America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
- 9.7.2. Latin America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
- 9.7.3. Latin America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
- 9.7.4. Latin America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.7.5. Targeted Protein Degradation Market - Mexico
  - 9.7.5.1. Mexico: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.7.5.2. Mexico: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.7.5.3. Mexico: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.7.5.4. Mexico: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.7.6. Targeted Protein Degradation Market - Brazil
  - 9.7.6.1. Brazil: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.7.6.2. Brazil: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.7.6.3. Brazil: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.7.6.4. Brazil: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.7.7. Targeted Protein Degradation Market - Argentina
  - 9.7.7.1. Argentina: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.7.7.2. Argentina: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.7.7.3. Argentina: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.7.7.4. Argentina: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
- 9.7.8. Targeted Protein Degradation Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Amphista Therapeutics Ltd.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Arvinas Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Betta Pharmaceuticals Co. Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bristol Myers Squibb Company
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. C4 Therapeutics Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Cullgen Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Dialectic Therapeutics Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Kymera Therapeutics Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Monte Rosa Therapeutics Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Nurix Therapeutics Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Pfizer Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Relay Therapeutics Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development

Product Code: PM5247

List of Tables:

Table 1 Global Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 2 Global Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 3 Global Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 4 Global Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 5 North America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 6 North America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 7 North America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 8 North America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 9 U.S.: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 10 U.S.: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 11 U.S.: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 12 U.S.: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 13 Canada: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 14 Canada: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 15 Canada: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 16 Canada: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 17 Europe: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 18 Europe: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 19 Europe: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 20 Europe: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 21 UK: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 22 UK: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 23 UK: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 24 UK: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 25 France: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 26 France: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 27 France: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 28 France: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 29 Germany: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 30 Germany: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 31 Germany: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 32 Germany: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 33 Italy: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 34 Italy: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 35 Italy: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 36 Italy: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 37 Spain: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 38 Spain: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 39 Spain: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 40 Spain: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 41 Netherlands: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 42 Netherlands: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 43 Netherlands: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 44 Netherlands: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 45 Russia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 46 Russia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 47 Russia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 48 Russia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 49 Rest of Europe: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 50 Rest of Europe: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 51 Rest of Europe: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 52 Rest of Europe: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 53 Asia Pacific: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 54 Asia Pacific: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 55 Asia Pacific: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 56 Asia Pacific: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 57 China: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 58 China: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 59 China: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 60 China: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 61 India: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 62 India: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 63 India: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 64 India: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 65 Malaysia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 66 Malaysia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 67 Malaysia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 68 Malaysia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 69 Japan: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 70 Japan: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 71 Japan: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 72 Japan: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 73 Indonesia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 74 Indonesia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 75 Indonesia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 76 Indonesia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 77 South Korea: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 78 South Korea: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 79 South Korea: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 80 South Korea: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 81 Australia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 82 Australia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 83 Australia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 84 Australia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 85 Rest of Asia Pacific: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 86 Rest of Asia Pacific: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 87 Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 88 Rest of Asia Pacific: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 89 Middle East & Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 90 Middle East & Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 91 Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 92 Middle East & Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 93 Saudi Arabia: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 94 Saudi Arabia: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 95 Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 96 Saudi Arabia: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 97 UAE: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 98 UAE: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 99 UAE: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 100 UAE: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 101 Israel: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 102 Israel: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 103 Israel: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 104 Israel: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 105 South Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 106 South Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 107 South Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 108 South Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 109 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 110 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 111 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 112 Rest of Middle East & Africa: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 113 Latin America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 114 Latin America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 115 Latin America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 116 Latin America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 117 Mexico: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 118 Mexico: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 119 Mexico: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 120 Mexico: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 121 Brazil: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 122 Brazil: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 123 Brazil: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 124 Brazil: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 125 Argentina: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 126 Argentina: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 127 Argentina: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 128 Argentina: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)
Table 129 Rest of Latin America: Targeted Protein Degradation Market, by Technology, 2021-2034 (USD Million)
Table 130 Rest of Latin America: Targeted Protein Degradation Market, by Application, 2021-2034 (USD Million)
Table 131 Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic, 2021-2034 (USD Million)
Table 132 Rest of Latin America: Targeted Protein Degradation Market, by End-user, 2021-2034 (USD Million)

List of Figures:

Figure 1. Global Targeted Protein Degradation Market, 2021-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Technology
Figure 7. Global Targeted Protein Degradation Market, by Technology, 2025 & 2034 (USD Million)
Figure 8. Market by Application
Figure 9. Global Targeted Protein Degradation Market, by Application, 2025 & 2034 (USD Million)
Figure 10. Market by Therapeutic
Figure 11. Global Targeted Protein Degradation Market, by Therapeutic, 2025 & 2034 (USD Million)
Figure 12. Market by End-user
Figure 13. Global Targeted Protein Degradation Market, by End-user, 2025 & 2034 (USD Million)

Targeted Protein Degradation Market Size, Share, Trends, & Industry Analysis Report By Technology, By Application, By Therapeutic Area, By End User, and By Region - Market Forecast, 2026-2034

Description

Table of Contents

List of Tables

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Targeted Protein Degradation Market Insights

5. Global Targeted Protein Degradation Market, by Technology

6. Global Targeted Protein Degradation Market, by Application

7. Global Targeted Protein Degradation Market, by Therapeutic

8. Global Targeted Protein Degradation Market, by End-user

9. Global Targeted Protein Degradation Market, by Geography

10. Competitive Landscape

11. Company Profiles

List of Tables:

List of Figures: